Real-time enrollment status for this primary membranous nephropathy clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 7:04 PM UTC
| NCT Number | NCT05696613 |
| Recruiting Status | Recruiting |
| Condition | Primary Membranous Nephropathy |
| Phase | PHASE3 |
| Target Enrollment | 148 participants |
| Active Locations | 19 sites in the US |
| Sponsor | Cerium Pharmaceuticals, Inc. |
| Last Updated on CT.gov | June 25, 2026 (3 weeks ago) |
As of July 17, 2026: Clinical trial NCT05696613 is currently recruiting participants. This phase3 study for primary membranous nephropathy is actively seeking new participants at 19 locations across the United States. The study is sponsored by Cerium Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05696613 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 19 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05696613 was last updated 3 weeks ago (June 25, 2026). HelloStudys verifies this status automatically.